[ Scientific Highlights ]
- Newer aspects of Type 2 DM Pathology
- Type 2 Diabetes Prevention: How to turn back the Clock & Change the Future?
- Is diabetes an inflammatory disease?
- Beyond A1c – New Outcomes for Diabetes
- Hypoglycaemia and vascular complications
- Multifactorial Approach to Type 2 Diabetes – Weight, BP and Lipids
- Diabetic Destiny – Pre-Life Exposure
- Sugar Coated Neurology: the sweet truth
- Reaching Composites Targets (HbA1c + SBP + LDC-C) in T2DM
- Fatty Liver Disease Impact on Diabetic Population
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring
- Shaping the Future: New Agents for Glucose Control
- Atherogenic Dyslipidaemia in Diabetes: What should the Clinician Do?
- Why are Remnant Particles of TRLs (Triglyceride Rich Lipoproteins) – The Killer in Diabetes?
- A Combination Approach: Targeting multiple defects of Diabetes
- Stem Cells as a Bio-Marker for Diabetes Medications
- Heart Failure: The often-forgotten Diabetes Complication
- Physiological Basis of Diabetes Therapies… and what we can learn from it
- Pre-Diabetes: Facts & Medication Guidance
- Evolution of Classification of DM: Glucose homeostasis and Beta Cell dysfunction in Indian DM
- Ageing Obesity & Diabetes: Molecular Connections & Clinical Implications
- Behind Insulin Resistance: Debugging the Endocrine System
- Amazing Science of Physical Exercise in Diabetes: Lessons learned so far
- Genome & Environment: Two Side Conspiracy in the Evolution towards Diabetes
- Recent Understanding on Glucagon – A Complex Hormone
- Glucocrinology – Pituitary, Thyroid, Parathyroid and Adrenals
- Bile Acid Regulation in Glucose Homeostasis
- Recent Advancement in the Alpha Cell and Beta Cells
Guidelines & Consensus
- The 2018 ADA/EASD Consensus report – Implications for Management of Type 2 Diabetes
- From CAEMELINA to HARMONY and beyond: How to the CVOT’s help us?
- CVOTS, their role and relevance in clinical Practice
- SGLT2i: From BIG data to Clinical Application
- How guidelines influence clinical management in Type 2 Diabetes
- Bridging the Gap between Clinical Trials & Clinical Practice in Type 2 Diabetes
- Glycaemic Control & beyond: Shifting the paradigm in Diabetes Care
- Early optimization of Cardio Metabolic Legacy in T2DM: lessons Post EMPA REG OUTCOME
- Life after DECLARE – A Changing lens for the Patients
- Updates on the outcome trials of Canagliflozin
- CVOT with Gliptins – What does Latest Evidence Say?
- Initiating Real World Evidence – Key findings from INITIAL Study
- Novel Markers for Screening Diabetes Complications
- Role of Physician in Managing Early Stage Diabetic Nephropathy
- Recent Trends in Diabetic Kidney Disease
- Kidney & CVD in Diabetes: Two side of the same coin?
- How to delay the Progression of Diabetic Nephropathy?
- Sugar Control in Patients with Renal Dysglycemia
- C. Peptide – Physiology to Clinical Use
- Novel Therapies for NASH
- Traditional Risk Factors of Diabetes: Can they Explain the Epidemics of Diabetes?
- Benedict’s Reagent to Precision Medicine in Diabetes: Are we at Cross Roads?
- Individualized Diabetes Care Across the Edge
- Point of Care in Diabetes Management
- Therapeutic Lifestyle Modification: Seed of the Hour
- Does Glycaemic Variability really matter?
Diabetes & Women
- Adolescent females with PCOS
- CV risk in Women with Diabetes
- Post-menopausal women with diabetes
- Differentiating Pre GDM-from GDM
- Managing a patient of Gestational Diabetes Mellitus
- Hyperglycaemia in the first trimester – why and how to prevent it?
- Diabesity: The recent Concern
- Weight Management in Clinical Practice
- Novel Anti-Obesity Drugs
- Mechanism for Cure of Diabetes by Metabolic Surgery
- High Protein Diet v/s Low Carbohydrate Diet: Which is better?
- Artificial Sweeteners in Diabetes: How Safe?
- VLCD – Ketogenic Diet: Is it safe in Health & Diabetes?
- Fruits in Diabetes: Myths & Realities
- Modification of Dietary Fats by Education on Nutrition in Schools & Training Physicians
- Metformin and the Gut: New Actions for an Old Drug
- Do SU Still have a Place in our Clinical Practice?
- Glitazone – Back from the Ashes
- Antiglycaemic Medication: What is in the Pipeline?
- Comparison of SGLT2i and GLP-1 for Vascular & Heart Health
- Newer AMPK Kinase Activator in the Management of Diabetes
- Type 1 Diabetes: Unmet Need & Future Directions
- Use of technology in Treatment of Type 1 Diabetes
- Latest Advances in Paediatric Diabetes
- Classification of Diabetes – 50 shades of grey: Type 1.5 (Flatbush), LADA, Type 3, Pancreatic
- Long-term complications of diabetes in youths
- Coping up with the diagnosis of type 1 DM – Insulin Motivation and Insulin Emotions
- Improving Glucose Control in Type 1 Diabetes
- Do We need to have a Paradigm Shift in Type 1 Diabetes Management?
- Decision support tools for T1D patients: First to Patients v/s First to Physicians
- Diabetes and Pulmonary Koch’s – A Deadly Combination
- Peculiar Infections in Diabetes
- OSA and Diabetes Link
- Lipodystrophy: Congenital & Acquired
- Asymptomatic Hyperuricemia: To Treat or Not
- Approach to Asymptomatic Bacteriuria in Diabetes
- Diabetes & NAFLD
- Diabetes & Cancer
- Diabetes & Bones
- Periodontitis in Diabetes
- Hypogonadism and Type 2 DM
- Managing Erectile Dysfunction with Normal Sex Hormones
Debates / Controversies
- Is prandial Insulin Dead in T2D?
- Is Insulin still the best injectable therapy?
- CVOT Trials in Diabetes: Should our management be dependent on these?
- Should SGLT2i be considered drugs for cardiologists?
- Should We use HbA1c for Diagnosis of Diabetes?
- Is bariatric surgery justified in childhood obesity?
- IDF – Diabetic Foot Symposium
- CODHY Symposium on Controversies in Diabetes
- ATTD Technology Symposium
- Diabetes Reversal Symposium
- Metabolic Surgery Symposium
- Insulin Pump Workshop
- Research Methodology Workshop
- Medical Writing Workshop
- Insulin Workshop
- Monitoring Workshop
- Educator’s Workshop
Meet the Experts
- Diabetes in Young
- Diabetes Management in Resource Constrained Setting
- Setting up a Diabetes Care Centre
- Use of Various Guidelines in Clinical Practice
Diabetes Premier League